{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cancer", "Chemotherapy", "In silico", "Inhibitors", "Medicinal plants"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38601803", "DateRevised": {"Year": "2024", "Month": "04", "Day": "12"}, "Article": {"Language": ["eng"], "ELocationID": ["28", "10.1007/s40203-024-00197-1"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "08"}], "Journal": {"ISSN": "2193-9616", "JournalIssue": {"Volume": "12", "Issue": "1", "PubDate": {"Year": "2024"}}, "Title": "In silico pharmacology", "ISOAbbreviation": "In Silico Pharmacol"}, "ArticleTitle": "Discovery of potential epidermal growth factor receptor inhibitors from black pepper for the treatment of lung cancer: an <i>in-silico</i> approach.", "Pagination": {"StartPage": "28", "MedlinePgn": "28"}, "Abstract": {"AbstractText": ["A tyrosine kinase receptor known as epidermal growth factor receptor (EGFR) is one of the main tumour markers in many cancer types and also plays a crucial role in cell proliferation, differentiation, angiogenesis, and apoptosis, which is a result of the auto-phosphorylations (kinase activity enhancement) that trigger signals involved in different cellular processes. Due to the discovery that non-small cell lung cancer (NSCLC) is a cause of this kinase activity enhancement, so far, several inhibitors have been tested against EGFR, but the side effects of these inhibitors necessitate an urgent measure to come up with an inhibitor that will be more specific to the cancer cells and not affect self-cells. This study was conducted to evaluate the efficacy of 37 compounds derived from Piper nigrum against EGFR using computer-aided drug design. Based on molecular docking, induced-fit docking, calculation of free binding energy, pharmacokinetics, QSAR prediction, and MD simulation. We propose five (5) lead compounds (clarkinol A, isodihydrofutoquinol B, Burchellin, kadsurin B, and lancifolin C) as a novel inhibitor, with clarkinol A demonstrating the highest binding affinity (-7.304\u00a0kcal/mol) with EGFR when compared with the standard drug (erlotinib). They also showed significant moderation for parameters investigated for a good pharmacokinetic profile, with a reliable R2 coefficient value predicted using QSAR models. The MD simulation of clarkinol A was found to be stable within the EGFR binding pocket throughout the 75\u00a0ns simulation run time. The findings showed that clarkinol A derived from Piper nigrum is worth further investigation and consideration as a possible EGFR inhibitor for the treatment of lung cancer.", "The online version contains supplementary material available at 10.1007/s40203-024-00197-1."], "CopyrightInformation": "\u00a9 The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}, {"Identifier": [], "Affiliation": "Teady Bioscience Research Laboratory, C28, Plural Gardens Estate, Akure, Ondo State Nigeria."}], "LastName": "Elekofehinti", "ForeName": "Olusola Olalekan", "Initials": "OO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}, {"Identifier": [], "Affiliation": "Teady Bioscience Research Laboratory, C28, Plural Gardens Estate, Akure, Ondo State Nigeria."}], "LastName": "Adetoyi", "ForeName": "Ifeoluwa Rachael", "Initials": "IR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Phytomedicine Biochemical Pharmacology and Toxicology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}], "LastName": "Popoola", "ForeName": "Hannah Oluwaseun", "Initials": "HO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}, {"Identifier": [], "Affiliation": "Teady Bioscience Research Laboratory, C28, Plural Gardens Estate, Akure, Ondo State Nigeria."}], "LastName": "Ayodeji", "ForeName": "Folasade Oluwatobiloba", "Initials": "FO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}, {"Identifier": [], "Affiliation": "Teady Bioscience Research Laboratory, C28, Plural Gardens Estate, Akure, Ondo State Nigeria."}], "LastName": "Taiwo", "ForeName": "Foluso Adeola", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}, {"Identifier": [], "Affiliation": "Teady Bioscience Research Laboratory, C28, Plural Gardens Estate, Akure, Ondo State Nigeria."}], "LastName": "Akinjiyan", "ForeName": "Moses Orimoloye", "Initials": "MO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Phytomedicine Biochemical Pharmacology and Toxicology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}], "LastName": "Koledoye", "ForeName": "Omowunmi Funmilayo", "Initials": "OF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/01pvx8v81", "grid.411257.4", "0000 0000 9518 4324"], "Affiliation": "Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State Nigeria."}, {"Identifier": [], "Affiliation": "Teady Bioscience Research Laboratory, C28, Plural Gardens Estate, Akure, Ondo State Nigeria."}], "LastName": "Iwaloye", "ForeName": "Opeyemi", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/009kx9832", "grid.412989.f", "0000 0000 8510 4538"], "Affiliation": "Department of Biochemistry, Faculty of Basic Medical Sciences, University of Jos, Jos, Plateau State Nigeria."}, {"Identifier": [], "Affiliation": "Bioinformatics Unit, Jaris Computational Biology Centre, Jos, Plateau State Nigeria."}], "LastName": "Adegboyega", "ForeName": "Abayomi Emmanuel", "Initials": "AE"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "In Silico Pharmacol", "NlmUniqueID": "101623954", "ISSNLinking": "2193-9616"}, "CoiStatement": "Conflict of interestThe authors declares that they have no conflict of interest"}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Acharya SG, Momin AH, Gajjar AV. Review of piperine as a bio-enhancer. Amer J PharmTech Res. 2012;2:32\u201344."}, {"Citation": "Ahmad N, Fazal H, Abbasi B, Farooq S, Ali M, Khan M. Biological role of Piper nigrum L. (Black pepper): a review. Asian Pac J Trop Biomed. 2012;2(3):S1945. doi: 10.1016/S2221-1691(12)60524-3.", "ArticleIdList": ["10.1016/S2221-1691(12)60524-3"]}, {"Citation": "Ahmad N, Fazal H, Abbasi BH, Farooq S, Ali M et al (2012) Biological role of Piper nigrum L. (Black pepper): A review. Asian Pacific Journal of Tropical Biomedicine: S1945-S1953"}, {"Citation": "Beniston M (2011) \u2018Alps\u2019, Encyclopedia of Earth Sciences Series, Part 3, 35\u201338, doi: 10.1007/978-90-481-2642-2_16"}, {"Citation": "Carcereny E, Mor\u00e1n T, Capdevila L, Cros S, Vil\u00e0 L, et al. The epidermal growth factor receptor (EGRF) in lung cancer. Trans Respir Med. 2015;3(1):1. doi: 10.1186/s40247-015-0013-z.", "ArticleIdList": ["10.1186/s40247-015-0013-z", "PMC4366432", "25810955"]}, {"Citation": "Schr\u00f6dinger Release 2018\u20132: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2018."}, {"Citation": "Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605\u2013644. doi: 10.1016/j.ccm.2011.09.001.", "ArticleIdList": ["10.1016/j.ccm.2011.09.001", "PMC3864624", "22054876"]}, {"Citation": "Daina A, Michielin O, Zoete V, et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "de Oliveira MT, Katekawa E. On the virtues of automated QSAR\u2014the new kid on the block. Future Med Chem. 2017 doi: 10.4155/FMC-2017-0170.", "ArticleIdList": ["10.4155/FMC-2017-0170", "29393678"]}, {"Citation": "Dixon SL, Duan J, Smith E, Von Bargen CD, Sherman W, Repasky MP. AutoQSAR: an automated machine learning tool for best-practice QSAR modeling. Future Med Chem. 2016;8:1825\u20131839. doi: 10.4155/fmc-2016-0093.", "ArticleIdList": ["10.4155/fmc-2016-0093", "27643715"]}, {"Citation": "Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449\u2013461. doi: 10.1517/17460441.2015.1032936.", "ArticleIdList": ["10.1517/17460441.2015.1032936", "PMC4487606", "25835573"]}, {"Citation": "Hadni H, Elhallaoui M. 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents. Heliyon. 2020;6(4):e03580. doi: 10.1016/j.heliyon.2020.e03580.", "ArticleIdList": ["10.1016/j.heliyon.2020.e03580", "PMC7168746", "32322700"]}, {"Citation": "Haq IU, Imran M, Nadeem M, Tufail T, Gondal TA, Mubarak MS. Piperine: A review of its biological effects. Phytother Res. 2021;35(2):680\u2013700. doi: 10.1002/ptr.6855.", "ArticleIdList": ["10.1002/ptr.6855", "32929825"]}, {"Citation": "Inamura K, Ninomiya H, Ishikawa Y, Matsubara O. Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features? Arch Pathol Lab Med. 2010;134:66\u201372. doi: 10.5858/2008-0586-RAR1.1.", "ArticleIdList": ["10.5858/2008-0586-RAR1.1", "20073607"]}, {"Citation": "Iwaloye O, Elekofehinti OO, Oluwarotimi EA, Babatomiwa K, Momoh I. Insilico molecular studies of natural compounds as possible anti-Alzheimer\u2019s agents: ligand-based design. Netw Model Anal Health Inform Bioinform. 2020;9:54. doi: 10.1007/s13721-020-00262-7.", "ArticleIdList": ["10.1007/s13721-020-00262-7"]}, {"Citation": "Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 2011;55:1169\u20131176. doi: 10.1002/mnfr.201100117.", "ArticleIdList": ["10.1002/mnfr.201100117", "PMC3295233", "21714124"]}, {"Citation": "Maione P, Sacco PC, Sgambato A, Casaluce F, Rossi A, Gridelli C. Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application. Ther Adv Med Oncol. 2015;7(5):263\u2013273. doi: 10.1177/1758834015595048.", "ArticleIdList": ["10.1177/1758834015595048", "PMC4543855", "26327924"]}, {"Citation": "Miller VA, Hirsh V, Cadranel J, Chen YM, Park K, Kim SW, Zhou C, Su WC, Wang M, Sun Y, Heo DS, Crino L, Tan EH, Chao TY, Shahidi M, Cong XJ, Lorence RM, Yang JC. Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial. Lancet Oncol. 2012;13(5):528\u2013538. doi: 10.1016/S1470-2045(12)70087-6.", "ArticleIdList": ["10.1016/S1470-2045(12)70087-6", "22452896"]}, {"Citation": "Nandi S, Bagchi MC. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: A rational approach to anticancer drug design. Mol Diversity. 2010;14:27\u201338. doi: 10.1007/s11030-009-9137-9.", "ArticleIdList": ["10.1007/s11030-009-9137-9", "19330460"]}, {"Citation": "Nandi S, Bagchi MC. In silico design of potent EGFR kinase inhibitors by structure-based screening of combinatorial libraries. Mol Simul. 2011;37:196\u2013209. doi: 10.1080/08927022.2010.536542.", "ArticleIdList": ["10.1080/08927022.2010.536542"]}, {"Citation": "Nandi S, Bagchi MC. EGFr, FGFr and PDGFr: emerging targets for anticancer drug design. J Cancer Res. 2016;5:99\u2013108."}, {"Citation": "Nandi S, Dey R, Samadder A, Saxena AK. Natural sourced inhibitors of EGFR, PDGFR, FGFR and VEGFR-mediated signaling pathways as potential anticancer agents. Curr Med Chem. 2022;29(2):212\u2013234. doi: 10.2174/0929867328666210303101345.", "ArticleIdList": ["10.2174/0929867328666210303101345", "33655823"]}, {"Citation": "Nandi S, Dey R, Dey S, Samadder A, Saxena AK. Naturally sourced CDK inhibitors and current trends in structure-based synthetic anticancer drug design by crystallography. Anticancer Agents Med Chem. 2022;22(3):485\u2013498. doi: 10.2174/1871520621666210908101751.", "ArticleIdList": ["10.2174/1871520621666210908101751", "34503422"]}, {"Citation": "Paarakh PM, Sreeram DC. In vitro cytotoxic and in silico activity of piperine isolated from Piper nigrum fruits Linn. In Silico Pharmacology. 2015;3(1):9. doi: 10.1186/s40203-015-0013-2.", "ArticleIdList": ["10.1186/s40203-015-0013-2", "PMC4731375", "26820894"]}, {"Citation": "Parganiha R, Verma S, Chandrakar S, Pal S, Sawarkar HA, Kashyap P. In vitro anti- asthmatic activity of fruit extract of Piper nigrum (Piperaceae) Int J Herbs Pharmacol Res. 2011;1:15\u201318."}, {"Citation": "Sastry M, Lowrie JF, Dixon SL, Sherman W. Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J Chem Inf Model. 2010;50:771\u2013784. doi: 10.1021/ci100062n.", "ArticleIdList": ["10.1021/ci100062n", "20450209"]}, {"Citation": "Schrank Z, Chhabra G, Lin L, Iderzorig T, Osude C, Khan N, Kuckovic A, Singh S, Miller RJ, Puri N. Current molecular-targeted therapies in NSCLC and their mechanism of resistance. Cancers. 2018;10(7):224. doi: 10.3390/cancers10070224.", "ArticleIdList": ["10.3390/cancers10070224", "PMC6071023", "29973561"]}, {"Citation": "Schr\u00f6dinger Release 201 8\u20134: LigPrep (2018) Schr\u00f6dinger. LLC, New York, NY. 2018"}, {"Citation": "Schr\u00f6dinger Release 2020\u20132: Induced Fit Docking protocol; Glide, Schr\u00f6dinger, LLC, New York, NY (2016) Prime, Schr\u00f6dinger, LLC, New York, NY, 2020"}, {"Citation": "Schr\u00f6dinger Release 2020\u20132: Prime, Schr\u00f6dinger. New York, NY: LLC, 2020."}, {"Citation": "Sitki-Copur M. State of cancer research around the globe. Oncol J. 2019;33(5):181\u2013185.", "ArticleIdList": ["31095717"]}, {"Citation": "Schr\u00f6dinger Suite (2012) Protein Preparation Wizard; Epik version 2.3, Schr\u00f6dinger, LLC, New York, NY, 2012; Impact version 5.8, Schr\u00f6dinger, LLC, New York, NY, 2012; Prime version 3.1, Schr\u00f6dinger, LLC, New York, NY, 2012."}, {"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Vijayakumar S, Manogar P, Prabhu S, Singh RAS. Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease. J Pharm Anal. 2018;8:413\u2013420. doi: 10.1016/j.jpha.2017.07.006.", "ArticleIdList": ["10.1016/j.jpha.2017.07.006", "PMC6308024", "30595949"]}, {"Citation": "Yun CH, Boggon TJ, Li Y, Woo S, Greulich H, Meyerson M, Eck MJ. Structures of lung cancer-derived Egfr mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell. 2007;11:217. doi: 10.1016/j.ccr.2006.12.017.", "ArticleIdList": ["10.1016/j.ccr.2006.12.017", "PMC1939942", "17349580"]}]}], "History": [{"Year": "2023", "Month": "2", "Day": "2"}, {"Year": "2024", "Month": "2", "Day": "16"}, {"Year": "2025", "Month": "4", "Day": "8"}, {"Year": "2024", "Month": "4", "Day": "11", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "4", "Day": "11", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "4", "Day": "11", "Hour": "4", "Minute": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["38601803", "PMC11001845", "10.1007/s40203-024-00197-1", "197"]}}]}